← Back to Browse
ProductDiagnostic Tests

Cancer Treatment Efficacy Monitoring Test

China

Molecular diagnostic test for monitoring therapeutic response and detecting minimal residual disease in cancer patients. Supports ongoing treatment optimization and prognosis assessment.

Manufactured by

Shanghai Biotecan pharmaceuticals Co.,Ltd

China

Shanghai Biotecan Pharmaceuticals Co., Ltd., established in 2008, is a leading precision medicine enterprise in China with 17 subsidiaries. The company maintains strict quality management following GLP standards and consistently achieves perfect scores in CAP proficiency testing. Specializing in molecular diagnostics and medical big data analytics, Biotecan provides precision medicine services using advanced technologies.

View profile & products →

✦ Product-Specific Coverage

AI supplier coverage for this product

Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.

Generated for this product

AI-matched supplier coverage based on related product alternatives.

0
Relevant manufacturers
matched to this product
0
Relevant products analyzed
for supplier coverage
0
Sourcing countries
identified

Top sourcing countries

1China
56 relevant products
2United States
13 relevant products
3Germany
4 relevant products
🔒

18 more sourcing countries available

Get free access to all sourcing countries identified for this product.

See all countries →

See the full supplier coverage for this product

Get free access to all relevant manufacturers, sourcing countries, and product alternatives.

Get Free Access →

Free for medical industry professionals.

AI-Matched Alternative Products

from other manufacturers

AI-Matched Alternative Products

from other manufacturers

3 of 106 closest product alternatives

106 products

103 more product alternatives available

Create a free account to compare more product alternatives and supplier options.

Get Free Access →

© 2026 Suplivia · Home · Browse Products